Groundbreaking Parkinson’s trial publishes results

News

Author: Simge Eva DoganPublished: 7 March 2019

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Parkinson's trial

A breakthrough Parkinson’s trial that featured in a two-part documentary on UK television channel BBC Two has published its results.

The study, which featured in the documentary ‘The Parkinson’s Drug Trial: A miracle cure?’, aimed to investigate whether it was possible to restore damaged neurons by administering protein Glial Cell Line Derived Neurotrophic Factor (GDNF).

As part of the trial, scientists initially infused GDNF into the brains of six participants living with the condition. Researchers then invited a further 35 individuals with Parkinson’s to take part, with approximately half being administered with a placebo infusion.

Although not conclusive, the results suggest that GDNF had an impact on the brain and researchers believe the topic is worthy of further study.

Dr Alan Whone, principal investigator on the trial, said: “This represents some of the most compelling evidence yet that we may have a means to possibly reawaken and restore the dopamine brain cells that are gradually destroyed in Parkinson’s.

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.


Read more:

Course for Parkinson’s nurses launches in Slovenia

Could treadmill training improve Parkinson’s symptoms?

Go Back

Share this story

Comments


Related articles


medical marijuana and Parkinson's

Global update

Safety first: new guide offers advice on using herbal drugs to treat Parkinson’s

All the things you should consider before trying a plant-based drug

READ MORE

Perspectives

From New York to Toronto: the 500-mile walk that raised $750,000 for Parkinson’s research

500 miles, $750,000 and an unexpected visit from an old friend

READ MORE
young onset parkinsons

Interviews

Crowdfunded Irish feature film shines light on young onset Parkinson’s

We spoke to writer and director Chiara Viale

READ MORE